Bibliography
Vlodavsky, I., Friedmann, Y., Elkin, M., Aingorn, H., Atzmon, R., Ishai-Michaeli, R., Bitan, M., Pappo, O., Peretz, T., Michal, I., Spector, L., & Pecker, I. (1999). Mammalian heparanase: Gene cloning, expression and function in tumor progression and metastasis. Nature Medicine, 5(7), 793â802.
Authors
12
- Israel Vlodavsky (first)
- Yael Friedmann (additional)
- Michael Elkin (additional)
- Helena Aingorn (additional)
- Ruth Atzmon (additional)
- Rivka Ishai-Michaeli (additional)
- Menachem Bitan (additional)
- Orit Pappo (additional)
- Tuvia Peretz (additional)
- Israel Michal (additional)
- Larissa Spector (additional)
- Iris Pecker (additional)
References
50
Referenced
645
-
Kjellen, L. & Lindahl, U. Proteoglycans: structures and interactions. Annu. Rev. Biochem. 60, 443– 475 (1991).
(
10.1146/annurev.bi.60.070191.002303
) / Annu. Rev. Biochem. by L Kjellen (1991) -
David, G. Integral membrane heparan sulfate proteoglycan. FASEB J. 7, 1023–1030 (1993).
(
10.1096/fasebj.7.11.8370471
) / FASEB J. by G David (1993) -
Jackson, R.L., Busch, S.J. & Cardin, A.L. Glycosaminoglycans: Molecular properties, protein interactions and role in physiological processes. Physiol. Rev. 71, 481–539 (1991).
(
10.1152/physrev.1991.71.2.481
) / Physiol. Rev. by RL Jackson (1991) -
Wight, T.N., Kinsella, M.G. & Qwarnstromn, E.E. The role of proteoglycans in cell adhesion, migration and proliferation. Curr. Opin. Cell Biol. 4, 793–801 (1992).
(
10.1016/0955-0674(92)90102-I
) / Curr. Opin. Cell Biol. by TN Wight (1992) -
Rapraeger, A.C. The coordinated regulation of heparan sulfate, syndecans and cell behavior. Curr. Opin. Cell Biol. 5, 844– 853 (1993).
(
10.1016/0955-0674(93)90034-N
) / Curr. Opin. Cell Biol. by AC Rapraeger (1993) -
Wight, T.N. Cell biology of arterial proteoglycans. Arteriosclerosis 9, 1–20 (1989).
(
10.1161/01.ATV.9.1.1
) / Arteriosclerosis by TN Wight (1989) - Vlodavsky, I., Fuks, Z., Bar-Ner, M., Ariav, Y. & Schirrmacher, V. Lymphoma cell mediated degradation of sulfated proteoglycans in the subendothelial extracellular matrix: Relationship to tumor cell metastasis. Cancer Res. 43, 2704–2711 (1983). / Cancer Res. by I Vlodavsky (1983)
-
Nakajima, M., Irimura, T., DiFerrante, D., DiFerrante, N. & Nicholson, G.L. Heparan sulfate degradation: relation to tumor invasion and metastatic properties of mouse B16 melanoma sublines. Science 220, 611– 613 (1983).
(
10.1126/science.6220468
) / Science by M Nakajima (1983) -
Nakajima, M., Irimura, T. & Nicolson, G.L. Heparanase and tumor metastasis. J. Cell. Biochem. 36, 157–167 (1988).
(
10.1002/jcb.240360207
) / J. Cell. Biochem. by M Nakajima (1988) - Vlodavsky, I. et al. Inhibition of tumor metastasis by heparanase inhibiting species of heparin. Invasion Metastasis 14, 290– 302 (1995). / Invasion Metastasis by I Vlodavsky (1995)
-
Parish, C.R., Coombe, D.R., Jakobsen, K.B. & Underwood, P.A. Evidence that sulphated polysaccharides inhibit tumor metastasis by blocking tumor cell-derived heparanase. Int. J. Cancer 40, 511–517 (1987).
(
10.1002/ijc.2910400414
) / Int. J. Cancer by CR Parish (1987) -
Lider, O. et al. Suppression of experimental autoimmune diseases and prolongation of allograft survival by treatment of animals with heparinoid inhibitors of T lymphocyte heparanase. J. Clin. Invest. 83, 752–756 (1989).
(
10.1172/JCI113953
) / J. Clin. Invest. by O Lider (1989) -
Willenborg, D. O. & Parish, C. R. Inhibition of allergic encephalomyelitis in rats by treatment with sulfated polysaccharides. J. Immunol. 140, 3401– 3405 (1988).
(
10.4049/jimmunol.140.10.3401
) / J. Immunol. by DO Willenborg (1988) - Vlodavsky, I. et al. Expression of heparanase by platelets and circulating cells of the immune system: Possible involvement in diapedesis and extravasation. Invasion Metastasis 12, 112– 127 (1992). / Invasion Metastasis by I Vlodavsky (1992)
- Graham, L.D. & Underwood, P.A. Comparison of the heparanase enzymes from mouse melanoma cells, mouse macrophages and human platelets. Biochem. Mol. Biol. 39, 563– 571 (1996). / Biochem. Mol. Biol. by LD Graham (1996)
-
Ishai-Michaeli, R., Eldor, A. & Vlodavsky, I. Heparanase activity expressed by platelets, neutrophils and lymphoma cells releases active fibroblast growth factor from extracellular matrix. Cell Reg. 1, 833– 842 (1990).
(
10.1091/mbc.1.11.833
) / Cell Reg. by R Ishai-Michaeli (1990) -
Vlodavsky, I., Bar-Shavit, R., Ishai-Michaeli, R., Bashkin, P. & Fuks, Z. Extracellular sequestration and release of fibroblast growth factor: a regulatory mechanism? Trends Biochem. Sci. 16, 268–271 (1991).
(
10.1016/0968-0004(91)90102-2
) / Trends Biochem. Sci. by I Vlodavsky (1991) -
Eisenberg, S., Sehayek, E., Olivecrona, T. & Vlodavsky, I. Lipoprotein lipase enhances binding of lipoproteins to heparan sulfate on cell surfaces and extracellular matrix. J. Clin. Invest. 90, 2013–2021 (1992).
(
10.1172/JCI116081
) / J. Clin. Invest. by S Eisenberg (1992) -
Oosta, G.M., Favreau, L.V., Beeler, D.L. & Rosenberg, R.D. Purification and properties of human platelet heparitinase. J. Biol. Chem. 257, 11249–11255 (1982).
(
10.1016/S0021-9258(18)33749-9
) / J. Biol. Chem. by GM Oosta (1982) -
Freeman, C. & Parish, C.R. Human platelet heparanase: Purification, characterization and catalytic activity. Biochem. J. 330, 1341–1350 (1998).
(
10.1042/bj3301341
) / Biochem. J. by C Freeman (1998) -
Hoogewerf, A.J. et al. CXC chemokines connective tissue activating peptide-III and neutrophil activating peptide-2 are heparin/heparan sulfate-degrading enzymes. J. Biol. Chem. 270, 3268– 3277 (1995).
(
10.1074/jbc.270.7.3268
) / J. Biol. Chem. by AJ Hoogewerf (1995) -
Gonzalo, V. et al. Partial sequence of human platelet heparitinase and evidence of its ability to polymerize. Biochim. Biophys. Acta 1429, 431–438 (1999).
(
10.1016/S0167-4838(98)00254-4
) / Biochim. Biophys. Acta by V Gonzalo (1999) -
Jin, L., Nakajima, M. & Nicolson, G.L. Immunochemical localization of heparanase in mouse and human melanoma. Int. J. Cancer 45, 1088–1095 (1990).
(
10.1002/ijc.2910450618
) / Int. J. Cancer by L Jin (1990) -
De Vouge, M.W. et al. Immunoselection of GRP94/Endoplasmin from a KNRK cell specific g gt11 library using antibodies directed against a putative heparanase amino-terminal peptide. Int. J. Cancer 56, 286– 294 (1994).
(
10.1002/ijc.2910560224
) / Int. J. Cancer by MW De Vouge (1994) -
Goshen, R. et al. Purification and characterization of placental heparanase and its expression by cultured cytotrophoblasts. Mol. Hum. Reprod. 2, 679–684 (1996).
(
10.1093/molehr/2.9.679
) / Mol. Hum. Reprod. by R Goshen (1996) -
Bar-Ner, M., Eldor, A., Wasserman, L., Matzner, Y. & Vlodavsky, I. Inhibition of heparanase mediated degradation of extracellular matrix heparan sulfate by modified and non-anticoagulant heparin species. Blood 70, 551–557 (1987).
(
10.1182/blood.V70.2.551.551
) / Blood by M Bar-Ner (1987) -
Even-Ram, S. et al. Thrombin receptor overexpression in malignant and physiological invasion processes. Nature Med. 8, 909– 914 (1998).
(
10.1038/nm0898-909
) / Nature Med. by S Even-Ram (1998) -
Larizza, L., Schirrmacher, V. & Pfluger, E. Acquisition of high metastatic capacity after in vitro fusion of a non-metastatic tumor line with a bone marrow derived macrophage. J. Exp. Med. 160, 1579– 1584 (1984).
(
10.1084/jem.160.5.1579
) / J. Exp. Med. by L Larizza (1984) -
Klein, U. & Figura, K.V. Substrate specificity of a heparan-sulfate degrading endoglucuronidase from human placenta. Hoppe-Seyler's Z Physiol. Chem. 360, 1465–1471 (1979).
(
10.1515/bchm2.1979.360.2.1465
) / Hoppe-Seyler's Z Physiol. Chem. by U Klein (1979) -
Bame, K. J., & Robson K. Heparanases produce distinct populations of heparan sulfate glycosaminoglycans in Chinese hamster ovary cells. J. Biol. Chem. 272, 2245–2251 (1997).
(
10.1074/jbc.272.4.2245
) / J. Biol. Chem. by KJ Bame (1997) -
Sandback-Pikas, D., Li, J-P., Vlodavsky, I. & Lindahl, U. Substrate specificity of heparanases from human hepatoma and platelets. J. Biol. Chem. 273, 18770–18777 (1998).
(
10.1074/jbc.273.30.18770
) / J. Biol. Chem. by D Sandback-Pikas (1998) -
Pillarisetti, S. et al. Endothelial cell heparanase modulation of lipoprotein lipase activity. J. Biol. Chem. 272, 15753– 15759 (1997).
(
10.1074/jbc.272.25.15753
) / J. Biol. Chem. by S Pillarisetti (1997) -
Yahalom, J., Eldor, A., Fuks, Z. & Vlodavsky, I. Degradation of sulfated proteoglycans in the subendothelial extracellular matrix by human platelet heparitinase. J. Clin. Invest. 74, 1842–1849 (1984).
(
10.1172/JCI111603
) / J. Clin. Invest. by J Yahalom (1984) -
Bashkin, P., Razin, E., Eldor, A. & Vlodavsky, I. Degranulating mast cells secrete an endoglycosidase which degrades heparan sulfate in subendothelial extracellular matrix. Blood 75, 2204– 2212 (1990).
(
10.1182/blood.V75.11.2204.2204
) / Blood by P Bashkin (1990) -
Matzner, Y. et al. Degradation of heparan sulfate in the subendothelial basement membrane by a readily released heparanase from human neutrophils. J. Clin. Invest. 76, 1306–1313 (1985).
(
10.1172/JCI112104
) / J. Clin. Invest. by Y Matzner (1985) -
Naparstek, Y., Cohen, I.R., Fuks, Z. & Vlodavsky, I. Activated T lymphocytes produce a matrix-degrading heparan sulfate endoglycosidase. Nature 310, 241–243 (1984).
(
10.1038/310241a0
) / Nature by Y Naparstek (1984) -
Peretz, T. et al. Maintenance on extracellular matrix and expression of heparanase activity by human ovarian carcinoma cells from biopsy specimens. Int. J. Cancer 45, 1054–1060 (1990).
(
10.1002/ijc.2910450613
) / Int. J. Cancer by T Peretz (1990) -
Kleiner, D. E. & Stetler-Stevenson, W. G. Structural biochemstry and activation of matrix metalloproteases. Curr. Opin. Cell Biol. 5, 891–897 (1993).
(
10.1016/0955-0674(93)90040-W
) / Curr. Opin. Cell Biol. by DE Kleiner (1993) -
Stetler-Stevenson, W. G. Type IV collagenases in tumor invasion and metastasis. Cancer Metastasis Rev. 9, 289–303 (1990).
(
10.1007/BF00049520
) / Cancer Metastasis Rev. by WG Stetler-Stevenson (1990) -
Mignatti, P. & Rifkin, D. B. Biology and biochemistry of proteinases in tumor invasion. Physiol. Rev. 73, 161–195 (1993).
(
10.1152/physrev.1993.73.1.161
) / Physiol. Rev. by P Mignatti (1993) -
Bar-Ner, M. et al. Sequential degradation of heparan sulfate in the subendothelial extracellular matrix by highly metastatic lymphoma cells. Int. J. Cancer 35, 483–491 (1985).
(
10.1002/ijc.2910350411
) / Int. J. Cancer by M Bar-Ner (1985) - Vlodavsky, I. et al. in Tumor Angiogenesis (eds. Lewis, C.E., Bicknell, R &Ferrara, N.) 125–140 (Oxford University Press, Oxford, UK, 1997).
-
Vlodavsky, I., Bar-Shavit, R., Korner, G. & Fuks, Z. in Basement Membranes: Cellular and Molecular Aspects (eds. Rohrbach, D.H. & Timpl, R.) 327–343 (Academic, Orlando, Florida, 1993).
(
10.1016/B978-0-12-593165-6.50022-X
) -
Yayon, A., Klagsbrun, M., Esko, J.D., Leder, P. & Ornitz, D.M. Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell 64, 841– 848 (1991).
(
10.1016/0092-8674(91)90512-W
) / Cell by A Yayon (1991) -
Miao, H-Q., Ornitz, D. M., Eingorn, E., Ben-Sasson, S. A. & Vlodavsky I. Modulation of fibroblast growth factor-2 receptor binding, dimerization, signaling and angiogenic activity by a synthetic heparin-mimicking polyanionic compound. J. Clin. Invest. 99, 1565–1575 (1997).
(
10.1172/JCI119319
) / J. Clin. Invest. by H-Q Miao (1997) -
Vlodavsky, I. et al. Endothelial cell-derived basic fibroblast growth factor: Synthesis and deposition into subendothelial extracellular matrix. Proc. Natl. Acad. Sci. USA 84, 2292–2296 (1987).
(
10.1073/pnas.84.8.2292
) / Proc. Natl. Acad. Sci. USA by I Vlodavsky (1987) -
Vlodavsky, I. & Christofori, G. in Antiangiogenic Agents in Cancer Therapy (ed. Teicher, B.A.) 93–118 (Humana, Totowa, New Jersey, 1998).
(
10.1007/978-1-59259-453-5_7
) - Soule, H.D. et al. Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10. Cancer Res. 50, 6075–6086 (1990). / Cancer Res. by HD Soule (1990)
- Vlodavsky, I. in Current protocols in Cell Biology, Vol. I, Suppl. I (eds. Bonifacino, J.S., Dasso, M, Harford, J.B, Lippincott-Schwartz, J & Yamada, K.M.) 10.4.1–10.4.14 (John Wiley & Sons, New York, New York, 1999).
-
Savitsky, K. et al. Ataxia-telangiectasia: structural diversity of untranslated sequences suggests complex post-translational regulation of ATM gene expression. Nucleic Acids Res. 25, 1678– 1684 (1997).
(
10.1093/nar/25.9.1678
) / Nucleic Acids Res. by K Savitsky (1997)
Dates
Type | When |
---|---|
Created | 23 years, 1 month ago (July 26, 2002, 4:43 a.m.) |
Deposited | 2 years, 4 months ago (April 20, 2023, 7:35 p.m.) |
Indexed | 18 minutes ago (Sept. 6, 2025, 12:51 p.m.) |
Issued | 26 years, 2 months ago (July 1, 1999) |
Published | 26 years, 2 months ago (July 1, 1999) |
Published Online | 26 years, 2 months ago (July 1, 1999) |
Published Print | 26 years, 2 months ago (July 1, 1999) |
@article{Vlodavsky_1999, title={Mammalian heparanase: Gene cloning, expression and function in tumor progression and metastasis}, volume={5}, ISSN={1546-170X}, url={http://dx.doi.org/10.1038/10518}, DOI={10.1038/10518}, number={7}, journal={Nature Medicine}, publisher={Springer Science and Business Media LLC}, author={Vlodavsky, Israel and Friedmann, Yael and Elkin, Michael and Aingorn, Helena and Atzmon, Ruth and Ishai-Michaeli, Rivka and Bitan, Menachem and Pappo, Orit and Peretz, Tuvia and Michal, Israel and Spector, Larissa and Pecker, Iris}, year={1999}, month=jul, pages={793–802} }